11/9/2023 0 Comments Decode geneticsIn 1996, deCODE set up a laboratory with funding from abroad and started operations. The people of Iceland were more than willing to take part in the research program. In one of their published articles, they specified the behavioral and environment-related risk factors of Type 2 diabetes and heart diseases. They have applauded the contributions of deCODE genetics to society. These articles are avidly followed by foreign and Icelandic media. The company has published hundreds of articles to throw light on understanding the correct diagnosis for diseases like Alzheimer, Schizophrenia and other psychological disorders, more than a dozen types of cancer, and coronary artery diseases. Patients will be benefitted most as the identification of diseases will be easier and immediate treatment would start without any delay and risks. These partnerships provide funding for the research to enhance deCODE’s work, with the criteria of finding genetically validated new drug achievements in common diseases to develop DNA-based research. The company has signed high-profile partnerships with many pharmaceutical companies like Merck, Roche, Wyeth, and others. deCODE’s scientific leadership for more than two decades has pioneered new partnerships, applications, and products for many types of precision medicines. deCODE is one of the best enterprises globally to understand the human genome. The high profile scientists of deCODE genetics use a method to map the genes based upon the company’s genealogical database of the population of Iceland. Thus, treatment to cure the patient begins without wasting any time. In its ever-developing pharmacogenomics schedule, deCODE genetics has gathered the linkage approach with high expression profiling to produce tests that can accurately predict diseases present in the human body to near perfection. These types of tests play a vital role in delivering personalized medicines, enabling their contribution to delivering better means of diagnosing and treating many deadly diseases by providing each patient with the most suitable medicines. It has been able to apply its unparalleled discovery capacity to bring to the market new sets of drugs, pharmaceutical tests, and DNA-based diagnostic products. deCODE genetics has been successful in mapping genes in more than two dozen common and rare diseases. This unique combination enables them to find an effective system to identify key genes associated with the common diseases and to regulate the drug response. The William Allan award given by the American Society of Human Genetics recognizes Kári Stefánsson’s far-reaching scientific contribution to human genetics.ĭeCODE genetics has the world’s most detailed collection of phenotypes, genealogy, and genotypes. The founder of the company has been awarded the most prestigious award by the American Society of Human Genetics. They have the most productive human gene discovery engine in the world. They regularly publish their discoveries in well-known journals, so that even the general public are aware of their new successful experiments when they chance upon reading them. They have unique expertise in discovering key genetic risk factors for many common diseases ranging from cold and cough, flu, fever, dental, cardiovascular diseases to cancer, and a lot more. They aim to use population genetics, learn, and discover details about it, thereby developing novel methods to identify, prevent, and treat diseases. They specialize in identifying, treating, and preventing diseases by studying the variations in the human genome related to general diseases. It is a pharmaceutical company found in the year 1996 and is based in Reykjavik. DeCODE genetics is one of the best-known companies in Iceland and a global leader in researching the human genome.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |